Ind-Swift Laboratories Limited (INDSWFTLAB)
₹99.14
INR+4.72(+5.00%)
As of December 4, 2024 9:14:00 AMInd-Swift Laboratories Limited Share Price Information
24 hour Low and High
The lowest and highest prices reached in the last 24 hours of trading
Low: ₹89.93
High: ₹94.42
All time High
The highest price the stock has ever reached since being listed
₹176.72
Price Change 1h
Price change in the last hour of trading
+₹9.05 +10.05%
Price Change 1d
Price change over the last trading day
+₹9.05 +10.05%
Price Change 1w
Price change over the last week of trading
+₹ +%
Ind-Swift Laboratories Limited Market Information
Exchange
The Exchange where the trading of the stock takes place
NSE
Market Cap
The current market capitalisation of the stock
690.98 Cr
About Ind-Swift Laboratories Limited Share
Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimigraine, and thrombocytopenia. It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, azithromycin dihydrate, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, nitrosamine, pazopanib hydrochloride, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services. The company exports its products. Ind-Swift Laboratories Limited was incorporated in 1995 and is headquartered in Manimajra, India.
Sector
Healthcare
Drug Manufacturers - Specialty & Generic
Employees
about
47
CEO
Revenue (2023)
%
Country of Origin
India
Key Highlights
- Ind-Swift Laboratories Limited's (NSE:INDSWFTLAB) Revenues Are Not Doing Enough For Some Investors
- Private companies among Ind-Swift Laboratories Limited's (NSE:INDSWFTLAB) largest shareholders, saw gain in holdings value after stock jumped 12% last week
- Top stocks giving multi-year breakouts
- Ind-Swift Laboratories Q1 Results Live : profit falls by 94.57% YOY | Company Business News
- INDSWFTLAB Share Price Target 2024, 2025, 2026 To 2030
Ind-Swift Laboratories Limited Resource
FAQs
The current price of Ind-Swift Laboratories Limited is INR 99.14 — it has changed by 10.05% in the past 24 hours. Watch Ind-Swift Laboratories Limited's stock price performance more closely on the chart.
Ind-Swift Laboratories Limited has a market capitalization of 6909791232 as of today.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ind-Swift Laboratories Limited's EBITDA is INR undefined
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Ind-Swift Laboratories Limited stocks are traded under the ticker [object Object]
As of December 04, 2024, the company has 47 employees.